US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AdvisorShares Psychedelics ETF

25.15

+0.83003.41%

Post-market: 25.150.00000.00%19:57 EDT

Volume:16.47K

Turnover:411.22K

Market Cap:58.35M

PE:- -

High:25.38

Open:24.42

Low:24.42

Close:24.32

52wk High:27.02

52wk Low:15.63

Shares:2.32M

Float Shares:2.32M

Volume Ratio:0.39

T/O Rate:0.71%

Dividend:1.71

Dividend Rate:6.78%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Shionogi’s Phase 3 COVID-19 Antiviral Trial Puts SGIOF Back in the Spotlight

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), Twist Bioscience (TWST) and Medpace Holdings (MEDP)

Altitude Minerals Plans Major Equity Placement and Option Issue

$4.1m Capital Raising to Drive ABx Rare Earths and ALCORE Pilot Plant

Chariot Resources Plans Share and Option Placement to Boost Funding

Alkermes Appoints Anne Whitaker to Board of Directors

Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors

THOMSON REUTERS

Compass Pathways Joins TD Cowen Novel Mechanisms in Neuropsychiatry Summit Fireside Chat

NRx Pharma Says FDA Reclassifies Ketamine ANDA Amendment as Minor, Sets Nov. 10, 2026 Goal Date

NRx Pharmaceuticals says FDA reclassifies ANDA amendment to ‘minor’

NRX Pharmaceuticals - FDA Revises Gdufa Goal Date for Anda Amendment to November 10, 2026

THOMSON REUTERS

NRx Pharmaceuticals (Nasdaq: NRXP) Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free Ketamine

As Trump Backs Psychedelics Research, FDA Weighs Safety and Access Standards

Compass Pathways Launches ‘Change the Tune in Trd’ in the U.S. to Advance Hcp Understanding of Treatment-Resistant Depression at Psych Congress 2026

THOMSON REUTERS

Dataworks Group Plans Share and Option Issue to Support Growth

Dataworks launches A$4.24m capital raising to fund growth and strengthen balance sheet

Flynn Gold halts ASX trading ahead of capital raising announcement

Experts Urge FDA to Set Clear Safety and Access Standards for Psychedelic Drugs

NRX Pharmaceuticals Price Target Maintained with a $10.00/Share by BTIG

FDA to Hold Public Hearing on Psychedelic Drugs as Trump-Driven Push Gathers Pace

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/PSIL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"PSIL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","market":"US","secType":"STK","nameCN":"AdvisorShares Psychedelics ETF","latestPrice":25.15,"timestamp":1789675200000,"preClose":24.32,"halted":0,"volume":16472,"hourTrading":{"tag":"盘后","latestPrice":25.15,"preClose":25.15,"latestTime":"19:57 EDT","volume":57,"amount":1448.17,"timestamp":1789689420076,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.03412828947368414,"floatShares":2319976,"shares":2319976,"eps":0,"marketStatus":"Not Yet Opened","change":0.83,"latestTime":"09-17 16:00:00 EDT","open":24.42,"high":25.38,"low":24.42,"amount":411223.447056,"amplitude":0.039474,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789718400000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":24.32,"sharesOutstanding":1184976,"nav":24.367,"aum":56531795.79,"dividendRate":0.067801,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":23.75,"preClose":24.32,"latestTime":"08:32 EDT","volume":1,"amount":23.75,"timestamp":1789648345871,"change":-0.57,"changeRate":-0.023437,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":25.15,"preClose":25.15,"latestTime":"19:57 EDT","volume":57,"amount":1448.17,"timestamp":1789689420076,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.385739,"impliedVol":0.3448,"impliedVolPercentile":0.4861},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","floatShares":2319976,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.385739,"shares":2319976,"dividePrice":1.7052,"high":25.38,"amplitude":0.039474,"preClose":24.32,"low":24.42,"week52Low":15.6348,"pbRate":"--","week52High":27.0175,"institutionHeld":0,"latestPrice":25.15,"eps":0,"divideRate":0.067801,"volume":16472,"delay":0,"ttmEps":0,"open":24.42,"prevYearClose":17.17,"prevWeekClose":24.7682,"prevMonthClose":24.62,"prevQuarterClose":24.05,"fiveDayClose":24.7,"twentyDayClose":26.24,"sixtyDayClose":21.47},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PSIL\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PSIL","amount":1.68387,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2025-09-22","symbol":"PSIL","amount":0.02007,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-29","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-29"},{"date":"2025-06-23","symbol":"PSIL","amount":0.01191,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-03-21","symbol":"PSIL","amount":0.16343,"announcedDate":"2025-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-21","defaultRemindTime":1742563800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-21","currency":"USD","dateTimestamp":1742529600000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PSIL","amount":0.05477,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-30","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PSIL\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-26","recordDate":"2022-09-27","paymentDate":"2022-09-30","value":0.05421,"currency":"USD"},{"executeDate":"2023-09-25","recordDate":"2023-09-26","paymentDate":"2023-09-29","value":0.00336,"currency":"USD"},{"executeDate":"2024-09-23","recordDate":"2024-09-23","paymentDate":"2024-09-30","value":0.1087,"currency":"USD"},{"executeDate":"2024-12-23","recordDate":"2024-12-23","paymentDate":"2024-12-30","value":0.05477,"currency":"USD"},{"executeDate":"2025-03-21","recordDate":"2025-03-21","paymentDate":"2025-03-28","value":0.16343,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PSIL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PSIL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668999316","title":"Shionogi’s Phase 3 COVID-19 Antiviral Trial Puts SGIOF Back in the Spotlight","url":"https://stock-news.laohu8.com/highlight/detail?id=2668999316","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668999316?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:30","pubTimestamp":1789662653,"startTime":"0","endTime":"0","summary":"Shionogi & Co ($SGIOF) announced an update on their ongoing clinical study. Shionogi & Co. (SGIOF) is running a Phase 3 trial called “A Study of Se...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/shionogis-phase-3-covid-19-antiviral-trial-puts-sgiof-back-in-the-spotlight?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/shionogis-phase-3-covid-19-antiviral-trial-puts-sgiof-back-in-the-spotlight?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","BK4588","BK4007","BK4548","BK4139","BNTX","BBC","BK4568","SGIOF","BK4585","PSIL","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668996274","title":"Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), Twist Bioscience (TWST) and Medpace Holdings (MEDP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668996274","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668996274?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:30","pubTimestamp":1789648219,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alkermes (ALKS), Twist Bioscience (TWST) and Medpa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-twist-bioscience-twst-and-medpace-holdings-medp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-twist-bioscience-twst-and-medpace-holdings-medp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNOM","IBRN","XBI","XLV","FBT","ALKS","BK4139","BK4137","LU2065171311.SGD","LU2065169927.USD","ARKG","BK4588","BK4581","LABU","PSCH","MEDX","TWST","WDNA","HCSG","MEDP","IDNA","LU2065170008.USD","PSIL","BK4121","LU2065171402.SGD","LU0128526141.USD","LU0029874061.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668500934","title":"Altitude Minerals Plans Major Equity Placement and Option Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2668500934","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668500934?lang=en_us&edition=fundamental","pubTime":"2026-09-17 08:08","pubTimestamp":1789603700,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Copper Search Ltd. ( ($AU:ATT) ). Altitude Minerals Ltd has announced a proposed capital raising via a placemen...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/altitude-minerals-plans-major-equity-placement-and-option-issue?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/altitude-minerals-plans-major-equity-placement-and-option-issue?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SETM","BK4585","PICK","DBB","COPX","REZ","BK4535","BK4588","BK4215","BK4109","HGmain","MTX","PSIL","EQR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668931256","title":"$4.1m Capital Raising to Drive ABx Rare Earths and ALCORE Pilot Plant","url":"https://stock-news.laohu8.com/highlight/detail?id=2668931256","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668931256?lang=en_us&edition=fundamental","pubTime":"2026-09-17 07:58","pubTimestamp":1789603100,"startTime":"0","endTime":"0","summary":"An announcement from ABx Group Limited ( ($AU:ABX) ) is now available. ABx Group has secured binding commitments for a $4.1 million capital raising...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/4-1m-capital-raising-to-drive-abx-rare-earths-and-alcore-pilot-plant?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/4-1m-capital-raising-to-drive-abx-rare-earths-and-alcore-pilot-plant?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SETM","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668314249","title":"Chariot Resources Plans Share and Option Placement to Boost Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2668314249","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668314249?lang=en_us&edition=fundamental","pubTime":"2026-09-17 07:57","pubTimestamp":1789603075,"startTime":"0","endTime":"0","summary":"Chariot Corporation Limited ( ($AU:CC9) ) has issued an announcement. Chariot Resources Ltd has notified the ASX of a proposed capital raising via ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/chariot-resources-plans-share-and-option-placement-to-boost-funding?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/chariot-resources-plans-share-and-option-placement-to-boost-funding?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667607455","title":"Alkermes Appoints Anne Whitaker to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667607455","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667607455?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:00","pubTimestamp":1789556448,"startTime":"0","endTime":"0","summary":"Alkermes appoints Anne Whitaker to board of directorsAlkermes appointed Anne C. Whitaker as an independent director to its board.Whitaker is a biopharmaceutical executive with commercial, operational,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL86gXCW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","FBT","PSCH","MEDX","BK4139","IBRN","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667607123","title":"Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667607123","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667607123?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:00","pubTimestamp":1789556400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nTUA78XSXG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSCH","PSIL","BK4139","FBT","MEDX","IBRN","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667460228","title":"Compass Pathways Joins TD Cowen Novel Mechanisms in Neuropsychiatry Summit Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2667460228","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667460228?lang=en_us&edition=fundamental","pubTime":"2026-09-16 18:30","pubTimestamp":1789554631,"startTime":"0","endTime":"0","summary":"Compass Pathways joins TD Cowen Novel Mechanisms in Neuropsychiatry Summit fireside chatCompass Pathways will attend TD Cowen’s 6th Annual Novel Mechanisms in Neuropsychiatry Summit on Sept. 23, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL1sXVMd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PSIL","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667604726","title":"NRx Pharma Says FDA Reclassifies Ketamine ANDA Amendment as Minor, Sets Nov. 10, 2026 Goal Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2667604726","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667604726?lang=en_us&edition=fundamental","pubTime":"2026-09-16 18:04","pubTimestamp":1789553080,"startTime":"0","endTime":"0","summary":"NRx Pharma says FDA reclassifies ketamine ANDA amendment as minor, sets Nov. 10, 2026 goal dateNRX Pharmaceuticals received FDA notice reclassifying its ketamine ANDA amendment from major to minor, ea","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL16nC4D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP","BK4007","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667621742","title":"NRx Pharmaceuticals says FDA reclassifies ANDA amendment to ‘minor’","url":"https://stock-news.laohu8.com/highlight/detail?id=2667621742","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667621742?lang=en_us&edition=fundamental","pubTime":"2026-09-16 03:15","pubTimestamp":1789499711,"startTime":"0","endTime":"0","summary":"NRx Pharmaceuticals (NRXP) announced that it has received a written communication from the Director of Regulatory Operations of the FDA Office of G...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nrx-pharmaceuticals-says-fda-reclassifies-anda-amendment-to-minor-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nrx-pharmaceuticals-says-fda-reclassifies-anda-amendment-to-minor-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LABU","NRXP","PSIL","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667621265","title":"NRX Pharmaceuticals - FDA Revises Gdufa Goal Date for Anda Amendment to November 10, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2667621265","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667621265?lang=en_us&edition=fundamental","pubTime":"2026-09-16 03:11","pubTimestamp":1789499515,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570DV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRXP","PSIL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667624858","title":"NRx Pharmaceuticals (Nasdaq: NRXP) Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free Ketamine","url":"https://stock-news.laohu8.com/highlight/detail?id=2667624858","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667624858?lang=en_us&edition=fundamental","pubTime":"2026-09-16 03:11","pubTimestamp":1789499460,"startTime":"0","endTime":"0","summary":"Abbreviated New Drug Application (ANDA) Amendment related to the drug vial for preservative-free ketamine has been reclassified from a Major Amendment to a Minor Amendment.FDA has revised the Generic ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/15/3362609/0/en/nrx-pharmaceuticals-nasdaq-nrxp-reports-update-from-the-fda-revising-previous-major-amendment-to-a-minor-amendment-for-preservative-free-ketamine.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PSIL","NRXP","BK4585","LABU","LCLG","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667862533","title":"As Trump Backs Psychedelics Research, FDA Weighs Safety and Access Standards","url":"https://stock-news.laohu8.com/highlight/detail?id=2667862533","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667862533?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:16","pubTimestamp":1789485372,"startTime":"0","endTime":"0","summary":"The strongest evidence for use of the drugs so far has come from trials in patients with severe depression or post-traumatic stress disorder who have not responded to existing treatments.Early-stage trials are also testing psychedelic drugs for substance abuse disorders, borderline personality disorder, obsessive-compulsive disorders, anxiety, self-harm behavior, chronic Lyme disease and fibromyalgia.HOW DO PSYCHEDELIC TREATMENTS WORK?Psychedelic treatments work primarily by activating proteins on the surface of nerve cells that regulate the brain's ability to reorganize, form new connections, and repair damaged circuits. Unlike traditional psychiatric drugs that may be taken at home on a daily basis, these treatments are usually administered by medical personnel in a limited number of sessions to supplement intensive psychotherapy.WHAT PSYCHEDELIC DRUGS ARE CURRENTLY AUTHORIZED FOR USE?In the U.S. and Europe, the leading candidate for authorization is psilocybin, the active ingredient","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL1N4570B8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1280957306.USD","IE00B19Z3581.USD","IE00B42XCP33.USD","BK4581","IE0009355771.USD","LU2471134523.USD","IE000F7OJYX1.SGD","LU2129689514.USD","IE00BGHQF631.EUR","SG9999001176.SGD","LU1629891620.HKD","SGXZ80539844.SGD","LU0689472784.USD","LU1935042991.SGD","SG9999002224.SGD","IE000WAW04H5.SGD","IE00B1BXHZ80.USD","IE00BDGV0183.EUR","LU0964807845.USD","VHT","CMPS","LU1145028129.USD","LU1291159041.SGD","LU0943347566.SGD","FHLC","LU2471134796.USD","LU0472753341.HKD","LU2236285917.USD","LU2430703095.HKD","LU0345769631.USD","IE00BVYPNV92.GBP","IE00B19Z3B42.SGD","LU2129689431.USD","LU1043141396.HKD","IE00BLSP4239.USD","LU1057294990.SGD","LU1066051498.USD","LU0426412945.USD","LU0889566641.SGD","LU2430703178.SGD","LU0058720904.USD","LU0426417589.USD","BMED","LU0787776722.HKD","IE00BN8TJ469.HKD","LU1585245621.USD","LU1244550494.USD","BK4504","LU0114720955.EUR","LU0345769128.USD","IE0000B7K699.USD","LU2133065610.SGD","LU1244550221.USD","LU0289739699.SGD","MEDX","LU2487616109.SGD","LU2505996509.AUD","LU0053666078.USD","SGXZ57979304.SGD","LU0289961442.SGD","LU2505996681.GBP","LU1196500208.SGD","IE0002141913.USD","JDOC","LU0795875169.SGD","LU1032955483.USD","LU0057025933.USD","LU1162221912.USD","LU0820561818.USD","LU0345770993.USD","LU1894683264.USD","LU2750360641.GBP","XLV","LU0640476718.USD","LU1778281490.HKD","LU1221951129.SGD","LU2756315664.SGD","LU2756315318.SGD","LU2112291526.USD","LU1066051811.HKD","LU0070217475.USD","LU0912757837.SGD","LU1732799900.SGD","BK4559","GDOC","LU2347655156.SGD","LU1261432733.SGD","LU0511384066.AUD","SG9999001440.SGD","LU0820562030.AUD","LU0882574055.USD","IE00BLSP4452.SGD","LU1989771016.USD","LU0820561909.HKD","LU0234570918.USD","LU2430703251.USD","LU2471134952.CNY","IE000MB6IJN5.SGD","IE00BJT1NW94.SGD","IE0002270589.USD","LU1551013425.SGD","RXL","IE000BZT7R73.USD","BK4588","LU0289739343.SGD","LU1674673428.USD","LU0162691827.USD","IXJ","LU1894683348.USD","LU1674673691.USD","LU1043141123.HKD","LU0210536198.USD","LU1228905037.USD","LU2417539215.USD","LU2471134879.HKD","LU2750360997.AUD","PJP","LU0320765646.SGD","LU1506573853.SGD","IE00BSNM7G36.USD","LU1718418525.SGD","IE00BFXG1179.USD","LU0203347892.USD","JNJ","LU1032466523.USD","BK4592","LU1732800096.USD","PBM","LU2468319806.SGD","BK4007","LU0124676726.USD","IE00BZ1G4Q59.USD","LU1061106388.HKD","IE00BVYPNW00.USD","BK4533","LU0792757196.USD","LU1074936037.SGD","BK4534","LU2592432038.USD","LU0545562505.USD","LU1267930813.SGD","LU0689626769.HKD","IE0001KFT4U8.USD","BK4585","BK4550","LU2089984988.USD","LU0122379950.USD","PSIL","LU1059921491.USD","TRUH","LU2403377893.USD","LU1551013342.USD","IE00BFTCPJ56.SGD","LU0345770308.USD","LU1496350502.SGD","LU2456880835.USD","BK4532","LU0203345920.USD","IE0034235303.USD","LU1228905540.USD","IE000SO60NU8.SGD","LU1066053197.SGD","LU0994945656.USD","LU1914381329.SGD","LU1430594728.SGD","LU0432979614.USD","LU0072461881.USD","IE00B7SZLL34.SGD","LU2129689605.HKD","LU0985320562.USD","LU2023250330.USD","LU2602419157.SGD","IE00BBT3K403.USD","IHE","LU2896262040.SGD","LU0466842654.USD","LU1066051225.USD","SG9999001176.USD","LU1221951046.USD","IE00B4R5TH58.HKD","LU0795875086.SGD","IE00BKVL7J92.USD","LU0234572021.USD","LU2213496289.HKD","IE00B2B36J28.USD","LU1983299246.USD","LU1023059063.AUD","LU0098860793.USD","LU0683600562.USD","LU0069063385.USD","FTXH","IE00BJJMRZ35.SGD","BK4139","BK4568","IE000M9KFDE8.USD","IE00B3T34201.USD","SG9999013999.USD","LU0210528500.USD","IE00B3PB1722.GBP","LU1244550577.SGD","LU1121112475.USD","LU1929549753.HKD","IYH","SG9999002232.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667462036","title":"Compass Pathways Launches ‘Change the Tune in Trd’ in the U.S. to Advance Hcp Understanding of Treatment-Resistant Depression at Psych Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2667462036","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667462036?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:30","pubTimestamp":1789468200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nTUA90S5ST:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMPS","PSIL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667200691","title":"Dataworks Group Plans Share and Option Issue to Support Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2667200691","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667200691?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:54","pubTimestamp":1789430077,"startTime":"0","endTime":"0","summary":"IXUP Ltd. ( ($AU:DWG) ) has issued an announcement. Dataworks Group Limited has outlined plans for a new capital raising, proposing the issue of up...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dataworks-group-plans-share-and-option-issue-to-support-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dataworks-group-plans-share-and-option-issue-to-support-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667691733","title":"Dataworks launches A$4.24m capital raising to fund growth and strengthen balance sheet","url":"https://stock-news.laohu8.com/highlight/detail?id=2667691733","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667691733?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:54","pubTimestamp":1789430069,"startTime":"0","endTime":"0","summary":"IXUP Ltd. ( ($AU:DWG) ) has provided an announcement. Dataworks Group Limited has launched a capital raising of up to A$4.24 million comprising a A...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dataworks-launches-a4-24m-capital-raising-to-fund-growth-and-strengthen-balance-sheet?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dataworks-launches-a4-24m-capital-raising-to-fund-growth-and-strengthen-balance-sheet?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","SPHQ","PSIL","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667691316","title":"Flynn Gold halts ASX trading ahead of capital raising announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2667691316","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667691316?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:18","pubTimestamp":1789427896,"startTime":"0","endTime":"0","summary":"Flynn Gold Ltd. ( ($AU:FG1) ) just unveiled an update. Flynn Gold has requested and received a trading halt on its securities on the ASX as it prep...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/flynn-gold-halts-asx-trading-ahead-of-capital-raising-announcement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/flynn-gold-halts-asx-trading-ahead-of-capital-raising-announcement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["159934","SGCmain","518880","GLD","NUGT","GDX","DUST","PSIL","MGCmain","GCmain","SGUmain","IAU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667693327","title":"Experts Urge FDA to Set Clear Safety and Access Standards for Psychedelic Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2667693327","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667693327?lang=en_us&edition=fundamental","pubTime":"2026-09-15 03:30","pubTimestamp":1789414223,"startTime":"0","endTime":"0","summary":"UPDATE 2-Experts urge FDA to set clear safety and access standards for psychedelic drugsSept 14 (Reuters)-Doctors, veterans, pharmacists and therapists on Monday urged the U.S. Food and Drug Administr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL1N4560R3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMPS","DFTX","PSIL","BK4539","GHRS","ATAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667698261","title":"NRX Pharmaceuticals Price Target Maintained with a $10.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2667698261","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667698261?lang=en_us&edition=fundamental","pubTime":"2026-09-15 02:51","pubTimestamp":1789411860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NRXP/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP","BK4007","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667667454","title":"FDA to Hold Public Hearing on Psychedelic Drugs as Trump-Driven Push Gathers Pace","url":"https://stock-news.laohu8.com/highlight/detail?id=2667667454","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667667454?lang=en_us&edition=fundamental","pubTime":"2026-09-15 00:20","pubTimestamp":1789402802,"startTime":"0","endTime":"0","summary":"FDA to hold public hearing on psychedelic drugs as Trump-driven push gathers paceSept 14 (Reuters)-The U.S. Food and Drug Administration will hold a public hearing on Monday to gather feedback on the ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4N4531CQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GHRS","ATAI","DFTX","CMPS","PSIL","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}